JPMorgan to Finance Hi-Tech Pharmacal Sale to Akorn
Akorn and Hi-Tech Pharmacal entered into a definitive agreement under which Akorn will acquire Hi-Tech for $640 million in cash. JPMorgan committed the credit agreement consisting of a $600 million term loan and a $75 million revolver.
August 29, 2013
Akorn | Hi-Tech Pharmacal Co. | JPMorgan Chase
ABF Journal